This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Recent advances in cannabinoid therapeutics for Dravet syndrome

Join us at the at Complutense University of Madrid, Spain to explore the recent biomedical advances in cannabidiol for the treatment of seizures in Dravet syndrome.

Submit abstract

27–28 Oct 2022

Abstracts deadline: 05 Aug 2022

Registration deadline:

Complutense University of Madrid, Spain - View map

  • Overview
Find out more

Register now - Save up to nearly 1/3 on tickets when you register by 23 September 2022
Submit an abstract - Deadline 5 August 2022
 

The recent approval of Epidiolex (cannabidiol) for the treatment of seizures in Dravet syndrome and other infantile epileptic encephalopathies has led to cannabinoids being investigated for their potential as antiepileptic agents.

We invite you to our upcoming focussed meeting, Recent advances in cannabinoid therapeutics for Dravet syndrome, where you will explore and hear updates on these recent biomedical advances. You can join us in person at Complutense University of Madrid, Spain - one of the oldest operating universities in the world - or stream sessions via our digital platform.

If you have any questions, please contact meetings@bps.ac.uk.

 



Find out more

Register now - Save up to nearly 1/3 on tickets when you register by 23 September 2022
Submit an abstract - Deadline 5 August 2022